Novartis Research Foundation's FMI Director Susan Gasser: An Interview With "The Pink Sheet" DAILY (Part 2 Of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
The Director of the Friedrich Miescher Institute for Biomedical Research talks about the orphan drug space, and big pharma's growing interest in it.
You may also be interested in...
'Focused Diversification' Will Lead to Above-Average Growth, Says Novartis
Swiss group plans to outpace industry growth through maintaining R&D investment across chosen areas, and through improving efficiency.
'Focused Diversification' Will Lead to Above-Average Growth, Says Novartis
Swiss group plans to outpace industry growth through maintaining R&D investment across chosen areas, and through improving efficiency.
Novartis Research Foundation's FMI Director Susan Gasser: An Interview With "The Pink Sheet" DAILY (Part 1 Of 2)
The Director of the Friedrich Miescher Institute for Biomedical Research talks about discovery research, collaborating with Novartis and big pharma's interest in treating orphan diseases.